Chemokine Therapeutics Corp. Announces Board Changes
Published: Jul 21, 2008
VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 21, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases, today announced that Edward Taylor and Walter Korz have joined the Board of Directors. They will fill vacancies created by the resignations of Dr. Hassan Salari and Reza Bahadori. Dr. Salari has also resigned as the Company's part-time Chief Scientific Officer. Mr. Taylor will replace Dr. Salari as the Chairman of the Board.